Noninvasive genotyping fetal Kell blood group (<i>KEL1</i>) using cell‐free fetal DNA in maternal plasma by MALDI‐TOF mass spectrometry

Abstract

Our results indicated that the MALDI-TOF MS-based SABER has been used successfully for the detection of the fetal KEL1 status with the accuracy of 94%. Further, large-scale study, such as multicenter study, can now be explored for clinical application.